Bio-Techne (TECH) Non-Current Debt (2014 - 2026)

Bio-Techne has reported Non-Current Debt for 13 years, with the latest figure at $200.0 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt fell 39.39% year-over-year to $200.0 million; the trailing twelve-month figure through Mar 2026 stood at $200.0 million (down 39.39% YoY), and the FY2025 full-year result was $346.0 million, up 8.46% from the prior year.
• Non-Current Debt for Q1 2026 stood at $200.0 million, down from $260.0 million in the prior quarter.
• The five-year high for Non-Current Debt was $447.0 million in Q4 2023, with the low at $200.0 million in Q4 2022.
• Average Non-Current Debt over 5 years is $312.1 million, with a median of $300.0 million recorded in 2024.
• Year-over-year, Non-Current Debt jumped 123.5% in 2023 and sank 39.39% in 2026.
• Tracing TECH's Non-Current Debt over 5 years: stood at $200.0 million in 2022, then soared by 123.5% to $447.0 million in 2023, then slumped by 32.89% to $300.0 million in 2024, then retreated by 13.33% to $260.0 million in 2025, then slipped by 23.08% to $200.0 million in 2026.
• The last three Non-Current Debt figures came in at $200.0 million (Q1 2026), $260.0 million (Q4 2025), and $300.0 million (Q3 2025), per Business Quant data.

Peer Comparison